Rodney Brown

Vp, Managed Markets & Commercial Operations at Corcept Therapeutics

Rodney Brown has extensive work experience in the healthcare industry. Rodney began their career at Baxter International Inc., where they held various positions, including National Sales Training Manager and Group Director, National Accounts. Rodney then served as Senior Director, National Accounts at Durata Therapeutics, where they established a distribution channel strategy for a new IV antibiotic. Rodney later joined Healix, Inc. as VP of Sales, where they built and led a sales force for a sterile compounding facility. Rodney also worked at Takeda Pharmaceuticals as Head of Specialty Operations, overseeing sales analytics, market research, and sales training for a specialty medication. Rodney held the position of VP, Strategic Enterprises at Outcome Health, where they focused on improving patient engagement in outpatient clinical settings. Rodney continued their career at Achaogen as Head of Market Access, developing market access launch strategies for an IV antibiotic. Rodney then joined Gilead Sciences as a Business Market Access Lead before becoming SVP of Market Access at Summit Therapeutics. Rodney'smost recent role is VP of Managed Markets & Commercial Operations at Corcept Therapeutics. Throughout their career, Rodney has demonstrated strong leadership skills and expertise in market access and sales operations.

Rodney Brown obtained a Bachelor of Science (BS) degree in Biology, General from The University of Texas at San Antonio. Rodney completed this degree between 1986 and 1990. Subsequently, they pursued a Master of Arts (M.A.) degree in Health/Health Care Administration/Management from Webster University, graduating between 1995 and 1997.

Location

San Francisco, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices


Corcept Therapeutics

4 followers

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.


Industries

Employees

201-500

Links